• 0Shopping Cart
Gentegra LLC.
  • Home
  • About
    • Careers
    • News
    • Executive Team
    • Board of Directors
    • Contact
  • Technology
  • Products
    • GenTegra RNAdvantage™
    • GenTegra RNAssure™
    • Gentegra RNA
    • Forensic Applications of GenTegraDNA
    • Gentegra DNA
    • GenSolve Classic DNA Extraction
    • GenTegra Collection Cards
    • Product List
  • Manuals
  • Distributors
    • Collaborations
  • Search
  • Menu Menu

GenTegra Launches new GenTegra RNAssure™ for immediate protection of RNA following purification

Pleasanton, Calif. – As soon as RNA is purified and eluted from the column or removed from the magnetic beads any trace of RNase contamination will begin to degrade the RNA. GenTegra RNAssure is designed to replace the final collection tube in either purification method and immediately begin protecting the purified RNA. Not only immediate protection but RNAssure also provides protection for up to 4-days at room temperature. Protected in RNAssure the sample is no longer tied to an ice bucket during father time on the bench.

Additionally, when time comes to send the RNA sample off for RNAseq RNAssure allows for shipping on dry ice or following drying to be shipped at ambient temperatures with full protection. RNAssure is provided in a green flip top tube which makes it easily identifiable in the laboratory protocol. RNAssure is also purification kit agnostic. RNAssure can be used with virtually every RNA purification kit being sold.

The GenTegra RNAssure is available for immediate shipment in packages of 50 individual tubes. Sample test kits of three RNAssure tubes are available for evaluation. RNAssure is also available in PCR microplates and other formats.

About GenTegra LLC

GenTegra’s mission is to improve the quality of biological research and medical care by protecting sample integrity. GenTegra is committed to providing solutions for maintaining the pristine quality of biological specimens. The decisions made from the analysis of such specimens, whether it be viral samples from an emerging infectious disease, RNAseq samples shipped around the globe, or whole blood from patient-directed sampling devices, is only as good as the stability and quality of the sample.

For additional information, contact:
James Nelson,
VP Marketing, GenTegra LLC
jamesn@gentegra.com
https://gentegra.com/

Share this entry
  • Share on Facebook
  • Share on X
  • Share on X
  • Share on WhatsApp
  • Share on LinkedIn
  • Share on Reddit
  • Share by Mail

GENTEGRA

Home
About
Technology
Products
News
Distributors
Collaborations
Terms of Use
Terms of Sale
Privacy Policy

CONTACT US

1020 Serpentine Lane, Suite 110
Pleasanton, CA 94566, USA

Tel: 925 461 3010
Fax: 925 461 3086

Support: support@gentegra.com
Sales: sales@gentegra.com
Information: info@gentegra.com

© Copyright 2023 GenTegra® LLC. | All Rights Reserved - powered by Enfold WordPress Theme
  • LinkedIn
  • X
  • Youtube
GenTegra, LLC Announces New SARS-CoV-2 Sample Stabilization and Transport Products...GenTegra Expands Nucleic Acid Sample Stabilization Product Portfolio to Include...
Scroll to top